Recursion Pharmaceuticals Inc RXRX:NASDAQ
RT Quote | Last NASDAQ LS, VOL From CTA | USD
After Hours: Last | 7:59 PM EDT3.41
-0.06 (-1.73%)
-0.06 (-1.73%)Volume
380,465
Close
3.47-0.14 (-3.88%)
-0.14 (-3.88%)Volume
17,552,659
52 week range
2.77 - 7.18
- Open3.54
- Day High3.54
- Day Low3.37
- Prev Close3.61
- 52 Week High7.18
- 52 Week High Date10/20/25
- 52 Week Low2.77
- 52 Week Low Date05/19/26
Latest On Recursion Pharmaceuticals Inc
Key Stats
- Market Cap1.839B
- Shares Out529.91M
- 10 Day Average Volume21.90M
- Dividend-
- Dividend Yield-
- Beta1.00
Latest On Recursion Pharmaceuticals Inc
KEY STATS
- Open3.54
- Day High3.54
- Day Low3.37
- Prev Close3.61
- 52 Week High7.18
- 52 Week High Date10/20/25
- 52 Week Low2.77
- 52 Week Low Date05/19/26
- Market Cap1.839B
- Shares Out529.91M
- 10 Day Average Volume21.90M
- Dividend-
- Dividend Yield-
- Beta1.00
RATIOS/PROFITABILITY
- EPS (TTM)-1.20
- P/E (TTM)-2.88
- Fwd P/E (NTM)-3.78
- EBITDA (TTM)-494.863M
- ROE (TTM)-57.16%
- Revenue (TTM)66.408M
- Gross Margin (TTM)7.22%
- Net Margin (TTM)-842.93%
- Debt To Equity (MRQ)1.60%
EVENTS
- Earnings Date08/03/2026(est)
- Ex Div Date-
- Div Amount-
- Split Date-
- Split Factor-
Content From Our Affiliates
Related Video
watch now
Profile
MORERecursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology and chemistry to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components as iterative loops of atoms and bits, scaling wet lab biology and chemistry data...
Christopher Gibson Ph.D.
Chairman of the Board
Najat Khan Ph.D.
President, Chief Executive Officer
Ben Taylor
Chief Financial Officer, President of Recursion UK
Address
41S Rio Grande Street
Salt Lake City, UT
84101
United States